Your Article Summary
See Latest ArticlesCharacterizing Breast Cancer Xenograft Epidermal Growth Factor Receptor Expression by Using Near-Infrared Optical Imaging
Acta Radiologica, 06/12/09
Wang K et al. - Erbitux-Cy5.5 may be used as a specific NIR contrast agent for the noninvasive characterization of EGFR expression level in breast cancer xenografts.
Related Articles
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Relevance Score: 74%
Advanced Breast Cancer and Breast Cancer Mortality in Randomized Controlled Trials on Mammography Screening
Journal of Clinical Oncology, 11/09/09
Relevance Score: 72%
Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients
Breast Cancer Research and Treatment, 10/27/09
Relevance Score: 72%
Underweight and breast cancer recurrence and death: A report from the Korean breast cancer society
Journal of Clinical Oncology, 10/08/09
Relevance Score: 72%
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study
Cancer Epidemiology, Biomarkers & Prevention, 10/01/09
Relevance Score: 72%
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
Automatic Detection of Microaneurysms and Hemorrhages in Digital Fundus Images
Journal of Digital Imaging, 12/17/09
A "Building block" approach to application development for education and decision support in radiology: Implications for integrated clinical information systems environments
Journal of Digital Imaging, 12/17/09
A high-resolution networked computer system for radiologic instruction of medical students
Journal of Digital Imaging, 12/17/09